Year |
Citation |
Score |
2008 |
Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB. Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology. 149: 1581-90. PMID 18096662 DOI: 10.1210/En.2007-1148 |
0.676 |
|
2007 |
Takahashi N, Li F, Hua K, Deng J, Wang CH, Bowers RR, Bartness TJ, Kim HS, Harp JB. Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metabolism. 6: 506-12. PMID 18054319 DOI: 10.1016/J.Cmet.2007.10.011 |
0.349 |
|
2007 |
Cernkovich ER, Deng J, Hua K, Harp JB. Midkine is an autocrine activator of signal transducer and activator of transcription 3 in 3T3-L1 cells. Endocrinology. 148: 1598-604. PMID 17204554 DOI: 10.1210/En.2006-1106 |
0.69 |
|
2007 |
Cernkovich ER, Deng J, Bond MC, Harp JB. Adipose‐specific disruption of signal transducer and activator of transcription 3 (STAT3) increases body weight and adiposity The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A704-D |
0.675 |
|
2006 |
Deng J, Hua K, Caveney EJ, Takahashi N, Harp JB. Protein inhibitor of activated STAT3 inhibits adipogenic gene expression. Biochemical and Biophysical Research Communications. 339: 923-31. PMID 16329991 DOI: 10.1016/J.Bbrc.2005.10.217 |
0.544 |
|
2005 |
Graham KA, Gu H, Lieberman JA, Harp JB, Perkins DO. Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine. The American Journal of Psychiatry. 162: 1744-6. PMID 16135638 DOI: 10.1176/Appi.Ajp.162.9.1744 |
0.306 |
|
2005 |
Graham KA, Perkins DO, Edwards LJ, Barrier RC, Lieberman JA, Harp JB. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. The American Journal of Psychiatry. 162: 118-23. PMID 15625209 DOI: 10.1176/Appi.Ajp.162.1.118 |
0.37 |
|
2004 |
Harp JB. New insights into inhibitors of adipogenesis. Current Opinion in Lipidology. 15: 303-7. PMID 15166786 DOI: 10.1097/00041433-200406000-00010 |
0.334 |
|
2004 |
Hua K, Deng J, Harp JB. Interleukin-4 inhibits platelet-derived growth factor-induced preadipocyte proliferation. Cytokine. 25: 61-7. PMID 14693161 DOI: 10.1016/J.Cyto.2003.09.008 |
0.351 |
|
2004 |
Cole KA, Harmon AW, Harp JB, Patel YM. Rb regulates C/EBPbeta-DNA-binding activity during 3T3-L1 adipogenesis. American Journal of Physiology. Cell Physiology. 286: C349-54. PMID 14576085 DOI: 10.1152/Ajpcell.00255.2003 |
0.744 |
|
2002 |
Harmon AW, Patel YM, Harp JB. Genistein inhibits CCAAT/enhancer-binding protein beta (C/EBPbeta) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. The Biochemical Journal. 367: 203-8. PMID 12095417 DOI: 10.1042/Bj20020300 |
0.738 |
|
2001 |
Harmon AW, Harp JB. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. American Journal of Physiology. Cell Physiology. 280: C807-13. PMID 11245597 DOI: 10.1152/Ajpcell.2001.280.4.C807 |
0.739 |
|
2001 |
Harp JB, Franklin D, Vanderpuije AA, Gimble JM. Differential expression of signal transducers and activators of transcription during human adipogenesis Biochemical and Biophysical Research Communications. 281: 907-912. PMID 11237746 DOI: 10.1006/Bbrc.2001.4460 |
0.51 |
|
2000 |
Deng J, Hua K, Lesser SS, Harp JB. Activation of signal transducer and activator of transcription-3 during proliferative phases of 3T3-L1 adipogenesis. Endocrinology. 141: 2370-6. PMID 10875236 DOI: 10.1210/Endo.141.7.7551 |
0.585 |
|
2000 |
Deng J, Hua K, Lesser SS, Greiner AH, Walter AW, Marrero MB, Harp JB. Interleukin-4 mediates STAT6 activation in 3T3-L1 preadipocytes but not adipocytes. Biochemical and Biophysical Research Communications. 267: 516-20. PMID 10631093 DOI: 10.1006/Bbrc.1999.1993 |
0.448 |
|
1998 |
Venema RC, Ju H, Venema VJ, Schieffer B, Harp JB, Ling BN, Eaton DC, Marrero MB. Angiotensin II-induced association of phospholipase Cgamma1 with the G-protein-coupled AT1 receptor. The Journal of Biological Chemistry. 273: 7703-8. PMID 9516477 DOI: 10.1074/Jbc.273.13.7703 |
0.328 |
|
1998 |
Harp JB. An assessment of the efficacy and safety of orlistat for the long-term management of obesity Journal of Nutritional Biochemistry. 9: 516-521. DOI: 10.1016/S0955-2863(98)00006-0 |
0.319 |
|
Show low-probability matches. |